ASH 2010 Conference Coverage

Risk of thyroid cancer increases after a breast cancer diagnosis

Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.

Vaccine may delay recurrence for advanced ovarian cancers

Researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.

High fish intake may improve survival after breast cancer

Long-chain ω-3 polyunsaturated fatty acid intake from fish and other dietary sources may provide a potential strategy to improve survival after breast cancer, a new study published online early in the journal Cancer has found.

Adding bevacizumab to standard chemotherapy improves overall survival for women with ovarian cancer

Preliminary findings from the Gynecologic Oncology Group's (GOG) GOG 213 study show an improvement in overall survival for women with ovarian cancer when bevacizumab is added to standard chemotherapy.

African American cancer patients' depression symptoms often under-recognized

Depressed African American patients with cancer could be more accurately identified if the depression measures used are more culturally sensitive, according to a study.

Advanced thyroid cancer responds to targeted therapy with sunitinib

Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.

Fifteen new breast cancer genetic risk 'hot-spots' revealed

Researchers compared tiny variations in the genetic make-up of more than 120,000 women of European ancestry, with and without breast cancer, and identified 15 new genetic variations linked to a higher risk of the disease.

High fitness level may decrease risk of colorectal, lung cancers

Men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.

Discontinuing statin therapy safe, beneficial for patients with terminal illness

It is acceptable for patients with cancer and other life-limiting illness to discontinue statin medications.

Affect of chemotherapy on saliva test results

Do cancer treatments alter alleles affecting saliva, thus rendering a Genecept Assay null and void?

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs